Research at Baptist Health Louisville
Our Clinical Research Focuses on Tomorrow’s Patients Today
Baptist Health Louisville is committed to providing its patients with the best care possible. One way we do this is by conducting clinical trials and offering these opportunities to our patients. We conduct both treatment trials, which examine the safety and effectiveness of new drugs or therapies in managing your health condition and observational trials, which emphasize on data collection. Our research focus goes beyond cancer and heart health, but also stroke care, sleep disorders and bariatric research to name a few.
Reaching High Standards of Research
Our commitment to patient health is matched by our commitment to high standards of conduct and safety for all clinical-trial participants at Baptist Health Louisville. The expertise of our research personnel reflects this. Our research team consists of full-time licensed registered nurses. .
Good Citizen of the Research Community
The Baptist Health research team offers a number of services that are vital to the success of clinical research and testing:
- Participation in federal and commercially sponsored trials that provide new treatment opportunities for a variety of medical conditions and diseases
- Research coordination
- Trial-matching patients to studies taking place both inside and outside Baptist Health
- Collaboration with other hospitals and treatment centers to find the best possible fit between patients and research initiatives
Areas of Emphasis
Baptist Health Louisville has been involved in several groundbreaking research programs. Many of the therapies and drugs tested by our oncology program have become “gold-standard treatments” in the fight against cancer. In addition, we were recently awarded a federal grant to evaluate medical decision-making in the treatment of heart failure; a research project that we hope will improve the outcomes of patients both at Baptist Health and in the world at large.
Program Highlights
Below are highlights of some of the research being conducted at Baptist Health Louisville:
Cancer Trials:
- A071702: A Phase II Study of Checkpoint Blockade Immunotherapy in Patients with Somatically Hypermutated Recurrent Glioblastoma
- NRG BR-003: A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
- NRG BR-004: Paclitaxel/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
- TOL2506A: A Phase 3, Single Arm, Open-Label Study Evaluating Ovarian Suppression
- Following Three-Month Leuprolide Acetate For Injectable Suspension (TOL2506) in Combination with Endocrine Therapy in Premenopausal Subjects with Hormone-Receptor–Positive (HR+), Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer
- RTOG-0724: Phase III Randomized Study Of Concurrent Chemotherapy And Pelvic Radiation Therapy With Or Without Adjuvant Chemotherapy In High-Risk Patients With Early-Stage Cervical Carcinoma
- S1806: Phase III Randomized Trial of Concurrent Chemoradiotherapy with or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
- DS1062AU301: Phase 3 Randomized Study of DS-1062a Versus Docetaxel in previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer without Actionable Genomic Alterations (TROPION-Lung01)
- AB154CSP0002: A Phase 2 Study to Evaluate the Safety and Efficacy of AB122 Monotherapy, AB154 in Combination with AB122, and AB154 in Combination with AB122 and AB928 in Front-Line, Non-Small Cell Lung Cancer
- NRG-LU005: A Phase II/III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Cardiac Care:
- FLASH: Registry trial to evaluate the safety and effectiveness of the FlowTriever System for use in the removal of emboli from the pulmonary arteries in the treatment of acute pulmonary embolism (PE)
- DECIDE: A Multicenter Trial of a Shared Decision Support Intervention for Patients Offered Implantable Cardioverter-Defibrillators
- Bio-AffectDX: A-fib associated w/ HF treated by Biotronik's CRT-DX system.
Stroke Care:
- GERFHS-ROSE: Genetic and Environmental Risk Factors for Hemorrhagic Stroke
How to Contact Us
For general questions about the research program at Baptist Health Louisville, please contact our clinical research manager:
Melissa Barnes
Manager, Research Regulatory
Phone: 859.260.6363
Email: [email protected]
If you are currently participating in a trial and have a question, please contact your study coordinator, your physician, or the physician overseeing your study. Contact information is included with the consent documents you signed when you enrolled in the trial.
Where We Are Located
Baptist Health Louisville Research Department
4003 Kresge Way
Suite 131
Louisville, KY 40207
Learn more about Clinical Trials at Baptist Health.